PHIO PHARMACEUTICALS CORP. — Balance Sheet Charts
53 snapshots of history · ending 2024-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↓-38.7% -$4M
$6M
Current Assets↓-38.5% -$4M
$6M
Cash & Equivalents↓-36.6% -$3M
$5M
ST Investments↑+60.0% +$3M
$8M
Net PPE↓-66.7% -$4K
$2K
Total Liabilities↓-37.9% -$619K
$1M
Current Liabilities↓-37.9% -$619K
$1M
Account Payables↓-61.5% -$404K
$253K
Long-Term Debt↓-100.0% -$231K
$0
Stockholders Equity↓-38.9% -$3M
$5M
Retained Earnings↓-5.1% -$7M
$-146M
Operating Lease ROU Asset↓-100.0% -$33K
$0
Operating Lease Liability↓-100.0% -$35K
$0
Gross PP&E↓-73.0% -$834K
$308K
Accumulated Depreciation↓-73.1% -$830K
$306K